GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
The slimmed-down star is just one of the celebs who have embraced wood therapy massages to help break down fat and cellulite.
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...
Zacks.com on MSN23h
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy DesignationDenali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback